International Medicine and Health Guidance News ›› 2024, Vol. 30 ›› Issue (20): 3433-3437.DOI: 10.3760/cma.j.issn.1007-1245.2024.20.017

• Clinical Research • Previous Articles     Next Articles

Expressions of ErbB3 and miR-27a in esophageal cancer tissues and their relationships with clinical prognosis

Guo Xiaoning1, Zhu Wenlong2, Gong Huilin3, Liu Zhanfei2   

  1. 1 Department of Pathology, Yangling Demonstration Zone Hospital, Xianyang 712100, China; 2 Extrathoracic Oncology Department, Yangling Demonstration Zone Hospital, Xianyang 712100, China; 3 Department of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China

  • Received:2024-03-28 Online:2024-10-01 Published:2024-10-18
  • Contact: Liu Zhanfei, Email: 332448292@qq.com
  • Supported by:

    Shaanxi Province Key Research and Development Plan (2021KW-47)

食管癌组织中ErbB3、miR-27a表达情况及与临床预后的关系

郭晓宁1  朱文龙2  宫惠琳3  刘战飞2   

  1. 1杨凌示范区医院病理科,咸阳 712100;2杨凌示范区医院胸外肿瘤科,咸阳 712100;3西安交通大学第一附属医院病理科,西安 710061

  • 通讯作者: 刘战飞,Email:332448292@qq.com
  • 基金资助:

    陕西省重点研发计划(2021KW-47)

Abstract:

Objective To investigate the expressions of Erb-B2 receptor tyrosine kinase 3 (ErbB3) and microRNA-27A (miR-27a) in esophageal cancer tissues and their relationships with clinical prognosis. Methods A total of 120 patients with esophageal cancer admitted to the Department of Pathology, Yangling Demonstration Zone Hospital from June 2019 to June 2023 were retrospectively selected as the study objects. According to the Glasgow Prognostic Score (GPS), the patients were divided into a good prognosis group (97 cases) and a poor prognosis group (23 cases). Additionally, 50 healthy individuals undergoing routine health checks during the same period were selected as controls. The general data were compared between the good prognosis group and the poor prognosis group, and the expressions of ErbB3 and miR-27a were compared between the patients with esophageal cancer and the control group. Logistic regression analysis was used to analyze the factors influencing prognosis in patients with esophageal cancer, and a nomogram was constructed. Spearman correlation analysis was used to analyze the correlations between ErbB3 and miR-27a and prognosis. The predictive efficacies of ErbB3 and miR-27a for prognosis in patients with esophageal cancer were analyzed by the receiver operating characteristic curve (ROC). Independent sample t test, ANOVA, and χ2 test were used. Results There were 55 males and 42 females in the good prognosis group, aged 47-68 years. There were 14 males and 9 females in the poor prognosis group, aged 45-66 years. The proportions of the patients with stage III tumors and lymph node metastasis in the poor prognosis group were higher than those in the good prognosis group, and the proportion of the patients with low differentiation was lower than that in the good prognosis group (all P<0.05). The expression levels of ErbB3 [(1.59±0.45)] and miR-27a [(2.59±0.95)] in the poor prognosis group were higher than those in the good prognosis group [(1.28±0.37) and (1.84±0.52)] and the control group [(0.72±0.28) and (0.85±0.33)], and those in the good prognosis group were higher than those in the control group (all P<0.05). Logistic regression analysis showed that tumor stage, degree of differentiation, lymph node metastasis, and expressions of ErbB3 and miR-27a were all prognostic factors in patients with esophageal cancer (all P<0.05). Spearman correlation analysis showed that the expressions of ErbB3 and miR-27a in patients with esophageal cancer were positively correlated with GPS (r=0.294 and 0.282, P=0.001 and 0.002). ROC analysis results showed that the area under the curve (AUC) predicted by ErbB3 combined with miR-27a was greater than that predicted by ErbB3 or miR-27a alone (0.873 vs. 0.715 and 0.715). Conclusion The expressions of ErbB3 and miR-27a in esophageal cancer tissues have significant prognostic value for patients with esophageal cancer.

Key words:

Erb-B2 receptor tyrosine kinase 3, microRNA-27A, Esophageal cancer, Prognosis

摘要:

目的 探究食管癌组织中Erb-B2受体酪氨酸激酶3(ErbB3)、微RNA-27a(miR-27a)表达情况及与临床预后的关系。方法 回顾性选取2019年6月至2023年6月杨凌示范区医院病理科收治的120例食管癌患者作为研究对象。根据格拉斯哥预后评分(GPS)将患者分为预后良好组(97例)和预后不良组(23例)。选取50例同期体检的健康人员作为对照组。比较预后良好组和预后不良组一般资料,食管癌患者和对照组ErbB3、miR-27a表达水平。采用logistic回归分析食管癌患者预后的影响因素并构建列线图。采用Spearman相关性分析ErbB3、miR-27a与预后的相关性。采用受试者操作特征曲线(ROC)分析ErbB3、miR-27a对食管癌患者预后的预测效能。采用独立样本t检验、单因素方差分析和χ2检验。结果 预后良好组男55例,女42例;年龄47~68岁。预后不良组男14例,女9例;年龄45~66岁。预后不良组肿瘤分期Ⅲ期、淋巴结转移人数占比均高于预后良好组,低分化程度人数占比低于预后良好组(均P<0.05)。预后不良组ErbB3[(1.59±0.45)]、miR-27a[(2.59±0.95)]表达水平均高于预后良好组[(1.28±0.37)、(1.84±0.52)]和对照组[(0.72±0.28)(0.85±0.33)],且预后良好组均高于对照组(均P<0.05)。logistic回归分析显示,肿瘤分期、分化程度、淋巴结转移、ErbB3和miR-27a表达水平均是食管癌患者预后的影响因素(均P<0.05)。Spearman相关性分析显示,食管癌患者ErbB3、miR-27a表达水平均与GPS呈正相关(r=0.294、0.282,P=0.001、0.002)。ROC分析结果表明,ErbB3、miR-27a联合预测的曲线下面积(AUC)大于ErbB3、miR-27a单独预测(0.873比0.715、0.715)。结论 食管癌组织中ErbB3、miR-27a表达水平对食管癌患者预后有良好评估价值。

关键词:

Erb-B2受体酪氨酸激酶3, 微RNA-27a, 食管癌, 预后